Bilateral Hereditary kidney Cancer in Von Hippel Lindau’s Disease.
DOI:
https://doi.org/10.54212/27068048.v8i2.40Keywords:
Von Hippel-Lindau, renal cancer, clear cell carcinoma, SunitinibAbstract
OBJECTIVE: To present the clinical case of a patient diagnosed with bilateral clear cell renal cancer in her family variety of Von Hippel-Lindau
BACKGROUND: Renal cell cancer is the most predominant histological cancer of renal neoplasms in terms of bilateral appearance and its family origin is the unusual and leads to the documentation and presentation of this case.
MATERIALS AND METHODS: We present a case of a patient with a diagnosis of bilateral clear cell renal cancer in its faillure form of Von Hippel-Lindau as an anatomopathological finding after performing ultrasound-guided percutaneous biopsy.
RESULTS: Biopsy and histopathological study confirm the diagnosis
CONCLUSIONS: First line treatment in the management of patients with metastatic or bilateral renal cell carcinoma has been redirected to tyrosine kinase inhibitors.
Downloads
References
Wein, A, Kavoussi L, Novick A, Partin A, Peters C. Campbell-Walsh Urología 10ª Edición. Vol. 1, Madrid España: Panamerica. 20151431-1491
Peg X, Chen J, Wang J, Peng S, Liu S, Ma K, Zhou J, Hong B, Zhou B, Zhang J, Cai L, Gong K, Natura History of renal tumors in von Hippel-Lindau disease: a large retrospective study of Chinese patients. Med Genet [Internet] 2019 Feb 11 (citado 2020 Abr 3);2019(56)380-387. Disponible http://jmg.bmj.com . https://doi.org/10.1136/jmedgenet-2018-105567 DOI: https://doi.org/10.1136/jmedgenet-2018-105567
N'Dow J, Bjartell A, Briganti A, Cornford P, Knoll T, Ribal M, Sylvester R, Flensburg L, Van Poppel H. European Association of Urology Guidelines. 2019 Edición. Renal Cell Carcinoma. 358-410.
Schuhmacher P, Kim E, Hahn F, Sekula P, Jilg C, Leiber C, Neumann H, Schultze-Seemann W, Zschiedrich S. Growth characteristics and therapeutic decision markers in von Hippel-Lindau disease patients with renal cell carcinoma. Orphanet Journal of Rare Diseases [Internet] 2019 Oct. 23 (citado 2020 Abr 16);2019:1-8. Disponible en: https://doi.org/10.1186/s13023-019-1206-2 DOI: https://doi.org/10.1186/s13023-019-1206-2
Méjean A, Ravaud A, Thezenas S, Colas S, Beauval J, Bensalah K, Geoffrois L, Thiery-Vuillemin A, Cormier L, Lang H, Guy L, Gravis G. Sunitinib Alone or after Nephrectomy in Metastasic Renal-Cell Carcinoma. New Engalnda Journal of Medicine [Internet] 2018 Aug. 2 (citado 2019 Mar 20);379:417-427. Disponible en: https://www.nejm.org/doi/full/10.1056/NEJMoa1803675 https://doi.org/10.1056/NEJMoa1803675 DOI: https://doi.org/10.1056/NEJMoa1803675
Ma K, Hong B, Zhou J, Gong Y, Wang J, Liu S, Peng X, Zhou B, Zhang J, Xie H,Zhang K, Li L, Cai D, Wang Z, Cai L, Gong K. The Efficacy and Safety of Tyrosine Kinase Inhibitors for Von Hippel-Lindau Disease: A Retrospective Study of 32 Patients. Frontiers in Oncology [Internet] 2019 Nov. 1 (citado 2020 Abr 9);9)1122):1-10. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/31737565
https://doi.org/10.3389/fonc.2019.01122 DOI: https://doi.org/10.3389/fonc.2019.01122
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 Pablo Le Masson T., Erick Petersen J., Luis Muñoz V.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License 4.0 that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
